Allucent
Allucent, formed from the recent merger of CATO SMS and Pharm-Olam, is a global clinical services organization uniquely positioned to serve small and mid-sized biopharmaceutical companies. With over 30 years of experience, we understand how to develop and implement the right strategy throughout a product’s lifecycle. Our expertise encompasses all development phases (I-IV), solid tumors, and hemato-oncology indications. With an integrated approach encompassing regulatory, clinical, and scientific expertise, we’re adept at overcoming the challenges of complex therapeutic areas like oncology.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
No